Impaired expansion of mouse B cell progenitors lacking Btk  by Kerner, James D. et al.
Immunity, Vol. 3, 301-312, September, 1995, Copyright 0 1995 by Cell Press 
Impaired Expansion of Mouse B Cell Progenitors 
Lacking Btk 
James D. Kerner,* Mark W. Appleby,zs7 
Randolph N. Mohr,s Sylvia Chien,‘gz 
David J. Rawlings,5 Charles Ft. Malisxewski,6 
Owen N. Witte,‘q5 and Roger M. Perlmutter’*293V4 
‘Howard Hughes Medical Institute 
*Department of Immunology 
3Department of Biochemistry 
4Department of Medicine (Medical Genetics) 
University of Washington 
Seattle, Washington 98195 
5Department of Microbiology and Molecular Genetics 
University of California 
Los Angeles, California 90024 
6Department of Immunology 
lmmunex Corporation 
Seattle, Washington 98101 
Summary 
Mutations in the gene encoding the protein tyrosine 
kinase Btk are associated with the human B cell immu- 
nodeficiency X-linked agammaglobulinemia (XLA). In 
the mouse, a point mutation in the Btk pleckstrin ho- 
mology domain segregates with a milder X-linked im- 
munodeficiency (xid). To assess the importance of Btk 
function in murine lymphopolesis, we generated multi- 
ple embryonic stem cell clones bearing a targeted dis- 
ruption of the btk gene and examined their potential 
to produce lymphocytes in both C57BU6 and RAGP-‘- 
host chimeric animals. These mice provide a comple- 
mentary set of in vivo competition assays that formally 
establish the genetic basis for the xid phenotype. Al- 
though thenu/\mutationyieldsaphenotypequitesimi- 
lar to that of xid, it also compromises expansion of B 
cell precursors. Our results suggest that the murine 
and human consequences of Btk deficiency differ only 
quantitatively, and represent the same disease process. 
Introduction 
B lymphocytes develop from bone marrow progenitors via 
an ordered series of differentiative steps characterized by 
immunoglobulin gene rearrangement, proliferation, and 
the expression of numerous gene products (Osmond, 
1988; Hardy et al., 1989, 1991; Li et al., 1993; Melchers 
et al., 1994). Mutations in the gene encoding the Bruton 
tyrosine kinase (Btk; Rawlings and Witte, 1994; Conley et 
al., 1994; Smith et al., 1994a) are responsible for X-linked 
agammaglobulinemia (XLA), a severe primary immunode- 
ficiency of boys characterized by the virtually complete 
absence of circulating B lymphocytes. A mutation in the 
mouse brk gene is linked genetically with the relatively 
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mild X-linked immunodeficiency (xid) of CBA/N animals 
(Rawlings et al., 1993; Thomas et al., 1993). 
Btk is expressed widely throughout hematopoietic cell 
lineages, including nearly all stages of B cell development, 
but is found at negligible levels in T cells and is specifically 
down-regulated in plasma cells (Tsukada et al., 1993; de 
Weers et al., 1993; Smith et al., 1994b). The BTK locus, 
comprising 18 coding exons (Ohta et al., 1994) and map- 
ping to Xq22 in the human (Vetrie et al., 1993; Tsukada 
et al., 1993) encodes a 859 aa protein tyrosine kinase 
(PTK) homologous to Tee II (Mano et al., 1993) Bmx (Ta- 
magnoneetal., 1994),Txk(Haireet al., 1994) Itk(Yamada 
et al., 1993; Siliciano et al., 1992) and Dsrc 28C (Gregory 
et al., 1987). This subfamily of lineage-restricted nonre- 
ceptor PTKs is reminiscent of, but distinct from, the C-SE 
family of PTKs (reviewed by Perlmutter et al., 1993; Bolen, 
1993). The src family kinases participate in numerous sig- 
naling pathways as components of the signaling machin- 
ery linking membrane-associated receptors to the nucleus. 
Btk, like the src family PTKs, contains a unique N-ter- 
minal region, single SH3 and SH2 domains, and a kinase 
domain capable of both auto- and trans-phosphorylation. 
SH3 domains have been shown to interact with proteins 
containing a short proline-rich motif (Koch et al., 1991; 
Cicchetti et al., 1994; Ren et al., 1993) while SH2 domains 
interact with motifs containing phosphorylated tyrosine 
residues (Malek and Desiderio, 1993; Mayer et al., 1991; 
Pawson and Gish, 1992). The kinase domain of Btk pos- 
sesses the conserved autophosphorylation site of src fam- 
ily kinases, but lacks the C-terminal regulatory tyrosine 
residue. Btk also lacks the N-terminal glycine residue, 
which serves as a myristylation site in src family PTKs. 
The BTK N-terminal domain is unique, highly basic, and 
contains both a pleckstrin homology (PH) domain and two 
proline-rich motifs. PH domains, roughly 100 aa residues 
in length, are comprised of two antiparallel 6 sheets and 
a C-terminal a helix (Yoon et al., 1994; Ferguson et al., 
1994; Macias et al., 1994). The PH domains present in 
the 8 adrenergic receptor kinase @ARK) and phospholi- 
pase Cy have both been demonstrated to mediate binding 
to the f3y dimer of heterotrimeric G proteins that are liber- 
ated from the GTP-bound a subunit following receptor acti- 
vation (Koch et al., 1991; Touhara et al., 1994). Several 
PH domains have been shown to bind the membrane lipid 
phosphatidylinositol4,8bisphosphate as well, implying a 
role in membrane localization (Harlan et al., 1994). The 
PH domain of Btk is comprised of 137 residues divided 
into six interspersed subdomains (Musacchio et al., 1993); 
a single tryptophan (W-124) in subdomain 8 is conserved 
among all known PH domains (Shaw, 1993). Despite rela- 
tively low overall sequence similarity with the PH domain 
of f3ARK (80/o), the PH domain of Btk binds 8y in vivo and 
in vitro (Tsukada et al., 1994) with subdomains 5 and 6 
both necessary and sufficient for the interaction. In addi- 
tion, the Btk PH domain binds PKC 81,82, E, and < isoforms 
in vitro, and 61 in vivo in mast cells and B lymphocytes 
(Yao et al., 1994) leading to phosphorylation of Btk and 
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down-regulation of its kinase activity. Mutation of the 
highly conserved arginine at position 28 in subdomain 2 
has been observed in some patients with XLA (de Weers 
et al., 1994a; Ohta et al., 1994) and is associated with the 
xid phenotype in the mouse (Rawlings et al., 1993). The 
murine R28C mutation reduces PKC binding 3 to 5fold 
(Yao et al., 1994). In distinct contrast, replacement of gluta- 
mine at position 41 with lysine activates the kinase: this 
mutant exhibits increased membrane targeting and phos- 
phorylation on tyrosine, and its expression drives the 
growth of fibroblasts in soft agar and confers interleukind 
(IL-5) independence upon a B lineage cell line (Li et al., 
1995). In mast cells, FcsRl cross-linking induces activation 
and tyrosine phosphorylation of Btk, and measurable 
membrane translocation as well (Kawakami et al., 1994); 
similar activation occurs in B cells via surface immuno- 
globulin receptor ligation (Aoki, 1994; Saouaf et al., 1994; 
de Weers et al., 1994b). 
The CBA/N mouse (xid) has sewed as a model of mild 
X-linked B cell-intrinsic immunodeficiency for over 20 
years (Amsbaugh et al., 1972; Scher et al., 1973; reviewed 
by Wicker and Scher, 1986; Scher, 1982). Normal num- 
bers of pro-B, pre-B, and surface immunoglobulin-positive 
(lg’) B cells are present in the bone marrow (Reid and 
Osmond, 1985; Kincade et al., 1982) and Abelson leuke- 
mia virus targets are present in normal numbers (Kara- 
gogeos et al., 1986; Osmanetal., 1992) in thesemice.Peri- 
pheral B cell numbers, however, are significantly reduced 
(30% of normal), and exhibit an immature lgMbrighl, IgDdY1’, 
and class II major histocompatibility complex-dull 
(MHCdU”) phenotype. These animals do not produce an- 
tibody when challenged with polysaccharide thymic- 
independent type 2 (TI-2) antigens (Wicker and Scher, 
1986), and both IgM and lgG3 isotype levels are reduced 
(Perlmutter et al., 1979). In addition, B cell responses are 
either impaired or absent to a number of mitogenic stimuli, 
including lipopolysaccharide (Scher et al., 1975) surface 
immunoglobulin cross-linking (Sieckman et al., 1978) IL-5 
(Hitoshiet al., 1993) IL-lO(Goetal., 1990), CD38(Harada 
et al., 1993; Santos-Argumendo et al., 1995) and CD40 
ligand (Hasbold and Klaus, 1994). B cells in female mice 
heterozygous for the xid mutation generally express the 
wild-type X, and this skewing becomes nearly absolute in 
mice over 3 months of age (Forrester et al., 1987; Nahm 
et al., 1983). 
XLA was the first immunodeficiency to be described 
(Bruton, 1952) although its identification as a primary B 
cell immunodeficiency was more recent (Cooper et al., 
1971; Pearl et al., 1978; Conley, 1985; Tedder et al., 1985; 
Campana et al., 1990). In XLA patients, CD19+/CD34+ 
early pre-B cells are present in the bone marrow in normal 
numbers, with no skewing of X inactivation in female carri- 
ers (Conley et al., 1994). Many XLA patients, however, 
have reduced numbersof cytoplasmic p+/slg- pre-6 II cells 
(Campana et al., 1990) and in all patients studied the 
proliferative activity of cells at this stage appears consis- 
tently compromised. The phenotype of the few B cells that 
reach the periphery (less than 1% of normal numbers) is 
informative: these appear immature by virtue of the same 
surface-marker expression pattern that distinguishes xid 
B cells (Conley, 1985). 
Meaningful comparison of the phenotypes seen in XLA 
and xid is complicated by an incomplete understanding 
of the consequences of the murine R28C mutation. To 
address this issue, we have generated multiple embryonic 
stem cell (ES) clones bearing a targeted disruption of the 
murine bNc gene and analyzed their ability to produce lym- 
phocytes in somatic cell chimeras created by the injection 
of these Btk- ES cells into both wild-type and RAGP 
blastocysts. Our results provide formal proof that muta- 
tions in the btkgene are responsible for the xid phenotype, 
and suggest that only quantitative variation distinguishes 
between the phenotypes imposed by Btk- mutations in 
humans and mice. 
Results 
Disruption of the btk Gene in ES Cells and 
Generation of Somatic Cell Chimeric Mice 
Several electroporations of disruption vector BTKN. 1 (Fig- 
ure 1A) into two ES cell lines derived from the 129 mouse 
strain yielded multiple disrupted clones. Of 360 D3J8 ES 
clones from two electroporations, 6 (l/60) were scored 
as containing homologous integrants via genomic blotting 
(Figure 1 B); 315 REK2 clones were expanded from a sin- 
gle electroporation and 27 of 217 (l/8) analyzed clones 
contained the desired integration. The disruption elimi- 
nated exons 3 and 4, encoding all of PH subdomain 5, and 
most of subdomain 6 (including W124, the single most- 
conserved residue among known PH domains). Splicing 
from coding exons 2 to 5, if this occurs, would result in a 
frameshift mutation producing a stop in the first codon 
of exon 5. Reverse transcriptase-mediated polymerase 
chain reaction (RT-PCR) of sorted splenic B cells from 
wild-type (129) and RAGP-‘-IBtk- chimeric mice (Figure 
1C) revealed that this splicing event occurs with a high 
degree of fidelity. A single ES-derived amplification prod- 
uct, consistent with splicing of exons 2 and 5 (Figure lC, 
left), resulted when primers from exons 2 and 12/l 3 were 
used, suggesting that splicing from exon 2 to other down- 
stream exons occurs rarely, if at all. To examine the speci- 
ficity of the mutant splicing event, both wild-type and mu- 
tant fragments generated from a second amplification 
strategy using primers from exon 1 and 516 (Figure lC, 
right) were isolated, cloned, and sequenced. We docu- 
mented normal splicing for 4 of 4 wild-type clones, and 
precise exon 2-to-5 splicing for 4 of 4 mutant clones (data 
not shown). There is no evidence that any truncated form 
of Btk is produced naturally from initiation at either of two 
potential translation sites downstream of the deleted ex- 
ons. In addition, the persistence of the known translational 
start site in exon 1 should render reinitiation quite ineffec- 
tive, even if such occurs, since the translational efficiency 
of downstream reading frames in polycistronic messages 
is reduced 40- to 300-fold in mammalian cells (Kaufman 
et al., 1987). Hence, this disruption almost certainly repre- 
sents a true null allele. 
Because both of our ES lines are genetically male, dis- 
ruption of a single allele is sufficient to create a null geno- 
type. Given the need for only a single round of selection, 
the rapidity with which results might be obtained, and the 
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Figure 1. Targeted Disruption of the Murine 
btk Gene 
(A) A partial restriction map of a 20 kb 129 
mouse genomic clone including btk coding ex- 
ons l-5 (top), targeting vector BTKN.l (mid- 
dle), and predicted integration via homologous 
recombination (bottom). Sizes indicated are 
those resulting from Hindlll digests, and con- 
tain coding exons 14 in the wild-type allele 
(10.5 kb), exons l-2 in the disrupted allele (8.0 
kb), and coding exon 5 (10 kb) in both. 
(6) Southern blot of Hind Ill digests of genomic 
DNA from three disrupted ES clones (minus) 
flanked by two wild-type ES DNA samples 
(plus). A cDNA probe comprising btk coding 
exons l-5 is completely external to the disrup 
tion vector and scores homologous integra- 
tional events (see [A]). Note that the lighter in- 
tensity band at 10.0 kb, representing exon 5, 
remains unchanged in the disrupted allele, 
while the 10.5 kb exon l-5 band is shifted to 
8.0 kb by the homologous event deleting exons 
3 and 4. The presence of single integrations 
and loss of exons 3 and 4 in disrupted clones 
were documented via additional probing strate- 
gies (data not shown). 
(C) RT-PCR of btk transcripts from sorted splenic B cells. Peripheral B cells (1 x 105) (B220+/CD3-) from a 129 control @VT’) and a Cmonth-old 
RAGT’-/Btk- chimeric mouse (KO) (derived from REK-2 Btk- clone 5130) were isolated by FACS. Total nucleic acid preparations were used for 
first-strand cDNA synthesis with primers corresponding to the thirteenth (left) or sixth (right) btk coding exons. Amplification with a 5’ primer 
corresponding to the start of coding exon 2 and a 3’ primer spanning the junction between exons 12 and 13 generates predicted fragments of 
1048 bp from wild-type transcripts and 897 bp from mutant transcripts lacking exons 3 and 4 (left), revealed via Southern blotting with an oligomeric 
probe (2’) corresponding to the 3’ end of exon 2. Probing with a pool of exon 3- and exon 4-derived oligomers demonstrates minor contamination 
of the chimeric B cells with RAGP-‘--derived splenic monocytes. To address the fidelity of the predicted splicing from exons 2-5 in mutant-derived 
transcripts, first-strand cDNA was amplified with a 5’ primer corresponding to the start of coding exon 1 and a 3’ primer spanning exons 5 and 
6. Fragments consistent with predicted sizes (531 bp for wild-type, 380 bp for mutant) were identified (right). Again, a minor wild-type transcript 
contamination from RAGP“-derived cells was observed following probing with the combination of exon 3 and 4 oligomers. Mutant and wild-type PCR 
products were cloned and sequenced, revealing precise splicing from btk exons 2-5 (thereby introducing a termination codon) in mutant products (data 
not shown). 
possibility of the detection of subtle competitive deficien- 
cies not seen in animals uniformly deficient in Btk activity, 
we sought to evaluate the Btk- phenotype in chimeric 
animals. We selected as host blastocysts both normal 
C57BU6 (B6) embryos, and those from RAGP-‘- mice 
(Shinkaietal., 1992) whichlackafunctionalgeneinvolved 
in the initiation of immunoglobulin and T cell receptor gene 
rearrangements (Schatz et al., 1989; Oettinger et al., 
1991) and therefore do not produce any mature lympho- 
cytes. These alternative host strains permitted us to evalu- 
ate how Btk- ES-derived lymphocyte progenitors and their 
descendants might fare in distinct selective environments. 
Injection of ES cells from 8 Btk- clones into host blasto- 
cysts yielded 42 B6 host animal8 with both coat color and 
blood chimerism; similar injection into RAG hosts yielded 
10 chimeras representing three clones. Chimeric analyses 
were performed using these animals. 
Btk- B Lymphocytes Are Selectively Absent in the 
Periphery of B6 Chimeric Animals 
Expression of the 12Qspecific lymphoid cell marker Ly9.1 
(Mathieson et al., 1980; Lanier et al., 1981) permits the 
enumeration of ES-derived lymphocytes in B6 hosts 
(Gross et al., 1995). Figures 2A-2D show a representative 
set of flow cytometric profiles from spleen cells of an 
8-week-old REK2 Btk- ES-derived B6 chimera and age- 
matched B6control, illustratingthatchimericanimals have 
vastly greater ES contribution to the peripheral T cell lin- 
eage than to that for B cells. Similarly analyzed were 41 
other blood-chimeric animals derived from multiple REK2 
and D3J8 ES clones, with the consistent finding that Btk- 
ES-derived B cells are virtually absent in peripheral blood 
and spleen. The maximum percentage of B cell chimerism 
observed in the blood was 1.8% above background (Fig- 
ure 2, bottom). Of interest, scoreable B cell chimerism was 
evident almost exclusively in animals analyzed at 4 weeks 
of age or less (data not shown). T cell chimerism, on the 
other hand, was robust, reaching values of 15%-40%, 
and was stable with time. These T cells exhibited normal 
expression patterns of CD3, CD4, and CD8 (data not 
shown). 
Thymocyte Development Proceeds Normally 
in the Absence of Btk 
Within the thymi of B6 chimeric animals, Btk- ES-derived 
CD4-/CD8- cells progress through the 4+8+ stage to CD4 
and CD8 single-positive cells in a fashion indistinguishable 
from that of their B6 host counterparts (Figure 3). The 
representation of Btk- cells varied somewhat during devel- 
opment, but was, in general, consistent with levels ob- 
served in peripheral T cells (see Figure 2; Figure 3). The 
profiles in Figure 3 are representative of seven 4-week-old 
B6 chimeras derived from three independent Btk- ES 
clones. Overall chimerism in the thymus was lower in three 
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Figure 2. Btk- ES Cells Selectively Yield T Lymphocytes in the Periph- 
ery of B6-Host Chimeras 
Peripheral blood and spleen samples from C57BU6 control and 
C57BU6/Btkm ES chimeras (denoted as B6 chimeras) were depleted 
of red blood cells, stained with MAb against CD3, 8220, and Ly9.1, 
and analyzed by flow cytometry. B6 and 129 mice are polymorphic 
for the lymphoid cell surface antigen Ly9, permitting the tracking of 
ES-derived (129, Ly9.1+) lineages in a wild-type (B6, Ly9.1.) host. 
(Top) (A) and(B) show Ly9.1 distribution on CD3+ gated spleen samples 
from representative 86 (A), and B6 chimeric animals (B). (C) and (D) 
show Ly9.1 distribution on the 8220’ population from the same B6 
(C) and 86 chimeric (D) mice. The vertical cutoff shown in each box 
is derived from similar stains of control 129 splenic lymphocytes. Num- 
bers indicated are percentages of gated events falling into either of 
the two quadrants. 
(Bottom) Summary of peripheral lymphoid chimerism in eight B6 chi- 
meras. Data from analyses including those shown in (A-D) were used 
to determine the relative percent contribution of Btk- ES cells to periph- 
eral T and B cell populations. Ly9.1+ staining percentages from control 
B6 animals were subtracted from those of chimeric animals, with the 
resulting Ly9.1+ values reflecting true percent chimerism. These val- 
ues are plotted for peripheral blood stains from eight animals, and for 
splenic stains from six of the same mice. The data shown are from 
those animals having the highest levels of peripheral blood chimerism 
for both B and T lymphocytes. Scoreable peripheral B cell chimerism 
(never exceeding 1.6% above background) was observed only in ani- 
mals under 4 weeks of age. The eight animals represent five indepen- 
dent Btk- ES clones. A total of 42 such animals from eight independent 
Btk- ES clones derived from both REKP and D3J6 ES cell were ana- 
lyzed, and those not shown yielded similar results. 
8.4 (16.4) 88.6 (13.3) 
CDS . 
Figure 3. Btk- ES Cells Contribute to Normal Thymocyte Develop- 
ment in B6 Chimeras 
Thymocytes from a 4-week-old B6 chimera were stained with MAb 
against CD4, CD6, and Ly9.1, and analyzed by flow cytometry. The 
left panel shows total thymocytes (ES- and B6derived); the right panel 
shows the Ly9.1+ subset within the same thymus. Numbers shown 
represent percentages in each quadrant; numbers in parentheses indi- 
cate percent chimerism within a given quadrant. These profiles are 
representative of those obtained using seven other animals derived 
from three independent Btk- REKP ES clones. 
blood-chimeric animals analyzed at 4 months of age, al- 
though normal CD4/CD8 distributions were maintained 
among the ES-derived populations (data not shown). 
B Lymphocyte Precursor Expansion Is Compromised 
in Mutant Bone Marrow Populations 
The presence of low, yet measurable, numbers of Btk- 
ES-derived Bcells in the periphery of very young B6chime- 
ras indicated that B lineage development was occurring, 
albeit at a reduced rate. We therefore evaluated the pro- 
gression of ES-derived B lineage development in the bone 
marrow of these animals. The Ly9.1 marker is expressed 
on virtually all B220+ cells in 129 bone marrow, though at 
lower levels than on peripheral B cells (data not shown). 
This allowed us to follow ES-derived B lineage develop- 
ment in five 4-week-old B6 chimeras produced from REKP 
Btk- ES clone 5/52 (Figure 4). The expression patterns of 
CD43, 8220, and IgM on B lineage cells have been used 
to define several B lineage subpopulations (Hardy et al., 
1991). A B220+/CD43+ group includes the earliest detect- 
able B lineages, pro- and pre-B I cells (approximately 2% 
of total bone marrow), while the B220+/CD43- population 
includes pre-B II and maturing B cells (approximately 20% 
of marrow). Among B22O+/CD43- cells, three populations 
can be defined: B220+/lgM- pre-B II cells, B220+/lgM+ im- 
mature B cells, and B220b”@VlgM+ mature B cells (normally 
representing on the order of lo%, 6%, and 4% of total 
marrow, respectively). As these percentages suggest, a 
dramatic proliferative expansion normally occurs between 
the pro- and pre-B II stages. Indeed, approximately 20% 
of pro/pre-B I cells, and 80% of large pre-B II cells (repre- 
senting 25% of total pre-B II) are actively cycling (Karasu- 
yama et al., 1994; Osmond, 1991). 
In B6 chimeric mice, we observed a normal degree of 
expansion of BG-derived progenitors between the pro-l 
pre-B I and pre-B II stages (Figure 4, lower left). In contrast, 
Btk- ES-derived pro-/pre-B I cells, present at levels consis- 
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tent with overall thymic chimerism for each of the five ani- 
mals studied, demonstrated a striking inability to yield ex- 
pected pre-6 II cell numbers within the same animals: little 
if any increase in abundance was observed in all five ani- 
mals between the ES-derived pro-lpre-6 I and pre-B II pop- 
ulations (Figure 4). Beyond the pre-B II stage, BG-derived 
B cells decreased in abundance as expected (since few 
of these cells are cycling, and some exit into the periphery), 
while Btk- ES-derived B cells declined to undetectable 
levels by the mature B cell stage. Whether the absence 
of mature Btk- ES-derived B cells in these bone marrow 
samples reflects cell death, early exit from the compart- 
ment, or inadequate recirculation from the periphery can- 
not be ascertained with certainty (see Figure 2). 
Peripheral B Cell Numbers Are Partially Rescued 
in RAGP-‘- Chimeric Hosts 
The relative rarity of ES-derived B cells attaining the pe- 
riphery of B6 chimeric animals precluded phenotypic anal- 
ysis of such cells. The RAG null blastocyst complementa- 
tion assay (Chen et al., 1993) has permitted lymphoid 
development from ES cell clones bearing disruptions of 
Figure 4. B Lymphocyte Progenitors Fail to 
Expand Numerically in B6 Chimeric Bone 
Marrow 
(Top) Bone marrow harvested from a 4-week- 
old 86 chimeric animal was depleted of red 
blood cells and stained with MAb against 8220, 
CD43, and LY9.1 or 8220, IgM, and Ly9.1. Top 
left, two-parameter stain for 8220 and CD43. 
Middle left, two-parameter stain for 8220 and 
IgM. Boxed areas represent 36% (A), 1.9% 
(pro- and praB I cells; [B]), 26% (pre-B II and 
maturing B; [Cl), 12% (pre-B II; [D]), 7% (imma- 
ture B; [El), and 5% (mature B; [F]) of total 
marrow nucleated cells. B-F show Ly9.1 distri- 
bution among the cells from each of these 
boxed populations. Numbers shown are per- 
centages of Ly9.1+ events, with background 
staining from 66 controls subtracted. (A) in- 
cludes Ly9.1’ cells as well, though additional 
stains demonstrate that these are primarily T 
lymphocytes (data not shown). 
(Bottom) Compilation of data from five 3- to 
4-week-old B6 chimeras derived from Btk- 
REK2 ES clone 5/52. Total numbers of pro/ 
pre-B I populations (B), separated into Ly9.1+ 
and Ly9.1- groups, were each set equal to a 
value of 1 .O. The table plots the expansion of 
the respective B6 and ES-derived populations 
into pre-B II (D). immature B(E), and mature B 
(F) compartments. Note that(D) includes pro-B 
and pre-B I cells. Hence, the defective expan- 
sion of this compartment in Btk- cells is slightly 
more profound than the calculation indicates. 
This method allows standardization of animal 
data independent of percent chimerism. Val- 
ues are mean f SEM. Note a greater than 
1 O-fold deficit (relative to wild type) in the ability 
of Btk- B lymphocyte progenitors to expand to 
or within the pre-B II stage. 
otherwise vital genes, including csk (Gross et al., 1995) 
c-jun (Chen et al., 1994), Rb (Chen et al., 1993), and vaw 
(Tarakhovsky et al., 1995; Zhang et al., 1995; Fischer et 
al., 1995). Since the RAGi? blockof lymphocyte develop- 
ment is absolute (Shinkai et al., 1992) we evaluated ma- 
ture B and T cell populations in RAGP-“IBtk- chimeras. 
We injected f?AGT’- blastocysts with ES cells represent- 
ing three independently derived Btk- ES clones (two from 
the D3J6 line and one from REK2). This environment 
proved more permissive for the development of Btk- B 
cells (Figure 5). Peripheral blood and spleen from chimeric 
animals contained both ES-derived T and B cells. Periph- 
eral blood (Figure 58) and spleen (Figure 5D) flow cytomet- 
ric profiles revealed 20%-l 00%1 of wild-type T cell abun- 
dance, and lo/o-15% wild-type B cell abundance. The 
peripheral B cell percentage was generally 6- to lo-fold 
less than that of T cells in the animals evaluated (Figure 
58). Both the relative percentages and the abundance of 
the two cell types remained stable for at least 6 months 
(data not shown). Of interest, the B cells present in the 
periphery of RAG chimeric animals consistently demon- 
strated the same IgMbO@VIgDdUrl phenotype characteristic 
of both xid and XLA B cells (Figure 5D). 
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respond to the TI-2 antigen merely represents a limiting 
r I titration of the two responses. These results demonstrate 
Figure 5. Btk- ES Cells Yield T Cells and Reduced Numbers of B Cells 
in ftAG2-‘1Btk ES Chimeras 
(A) and (B) Peripheral blood samples from 4-week-old control RAG2-‘+ 
(A) and RAG2”IBtk- chimeric animals (B) made using Btk- D3J6 ES 
clone 127 were depleted of red blood cells, stained with MAbs against 
8220 and CD3, and analyzed via two-color flow cytometry. 
(C) and (D) Spleen cells from similar animals were depleted of red cells 
and stained with MAbs against IgM and IgD. Numbers shown indicate 
percentages of boxed populations. Note the inset in (D), which shows 
a 129 splenic IgMllgD stain; the B lymphocyte box shows the relative 
position of cells in the RAG2’VBtk- chimera superimposed on this normal 
tracing. These results are representative of those obtained in analyzing 
seven animals from two D3JBderived clones and one REKLderived Btk- 
ES clone. B cell abundance in these animals ranged from l%-15% of 
wild-type levels, while T cell abundance ranged from 20%-l 00% that 
of wild type. Both the B/T cell ratios, and the absolute numbers of these 
cells, persist over time (data not shown). 
Btk- B Cells Respond Selectively to a 
Thymic-Dependent Antigen 
CBA/N mice bearing thexidmutation are characteristically 
nonresponsive to polysaccharide TI-2 antigens (Ams- 
baugh et al., 1972). Given the cell surface IgMllgD pheno- 
typic similarity of the Btk- B cells in RAGP-‘- chimeras 
(Figure 5D) with those seen in xid animals, we wished 
to extend the comparison to include immune responses. 
Figure 6 shows the humoral responses of 129, xid, 
RAG2+, and RAGP-‘-IBtk- ES chimeras to antigenic chal- 
lenge with a thymic-dependent (keyhole limpet hemocya- 
nin, KLH) and a TI-2 antigen (dinitrophenyl [DNPj-Ficoll). 
As expected, wild-type 129 animals mounted vigorous re- 
sponses to both antigens, particularly DNP-Ficoll, xidani- 
mals responded only to KLH, and RAG,?- animals were 
nonresponsive to both. The RAGZ’- chimeric response 
echoed that seen from the xid animals: three of the 
RAG,?- chimeras produced antibodies in response to 
KLH immunization, while none mounted any measurable 
response to DNP-Ficoll. Given that the wild-type (129) 
response to DNP-Ficoll is of greater magnitude than that 
to KLH (Figure 6, compare upper and lower left panels), 
it is unlikely that the failure of the ffAGT’- chimeras to 
that Btk- and xid B cells have a common defect in the 
ability to respond to a TI-2 antigen. 
Discussion 
We have generated somatic cell chimeric animals bearing 
cell populations with a null mutation in the gene encoding 
the protein tyrosine kinase Btk. These chimeric animals 
form an internally controlled set of competition experi- 
ments in which both Btk- Band T lymphocyte development 
can be evaluated against that of nonmutant progenitors. 
Choosing both wild-type (C57BU6) and RAG?‘- blasto- 
cysts as hosts for Btk- ES cells permitted us to control 
the degree of competition facing Btk- lymphoid progeni- 
tors (and their descendants). We studied the ability of Btk- 
T and B cells to colonize the periphery of both sets of 
animals, and noted a selective reduction in Btk- B lympho- 
cyte representation. Failure of expansion of early B lineage 
progenitors in the bone marrow of wild-type host chimeras 
appears to explain the low numbers of mutant B cells de- 
tected in the periphery of these animals. 
T Cell Development Proceeds Normally 
in the Absence of Btk 
In B6 host chimeric animals, Btk- ES-derived T cells com- 
pete well with their wild-type counterparts, contributing to 
as much as 40% of peripheral T cell abundance in some 
animals. Moreover, intrathymic development appeared 
virtually indistinguishable from that of B6 T cells. In RAG2+ 
hosts, normal T cell abundance was typically observed. 
In addition, the ability of Btk- B lymphocytes to respond 
to KLH documents that mutant T cells are able to deliver 
specific help towards antibody production. The finding of 
normal T cell development and function in the absence 
of Btk is not unexpected, since there is no consistent evi- 
dence from either XLA patients orxidanimals for any intrin- 
sicdefect in theTcell lineage (Richardset al., 1992; Crock- 
ard et al., 1992). Nonetheless, the presence of T cell 
chimerism proved a useful index for comparison with mu- 
tant B cell levels, and also formally demonstrates that an 
absence of mutant B cells could not be attributed to loss 
of any common lymphocytic precursor. 
Btk- B Cells Display an xid Phenotype 
in the Periphery of Chimeric Hosts 
In contrast with the abundance of Btk- ESderived T cells 
in the periphery of chimeric animals, virtually no mutant 
B cells were detected in either peripheral blood or spleen 
from most chimeras. An exception appears to be young 
mice: chimerism approaching 2% has been detected in 
animals assayed at under 4 weeks of age. This finding is 
consistent with previously published observations regard- 
ing the xid phenotype. The peripheral B cell population 
in female mice heterozygous for the xid mutation (xid/+) 
exhibits marked skewing of X inactivation in favor of the 
wild-type X chromosome, and this skewing progresses 
over time, becoming nearly absolute in mice over 3 months 
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Figure 6. Antibody Production by Btk- ES-derived B Cells 
We prebled and immunized three 129, two CBAINxid, three RAG control, and five RAG chimeras from D8J8 Btk- ES clone 127 2 months postweaning 
with 10 pg of DNP-Ficoll. The animals were bled 8 days later and immunized with 100 pg of KLH in a I:1 mixture with complete Freund’s adjuvant. 
A final bleed was performed after an additional 10 days. KLH and DNP IgM responses were measured via ELlSAs in serial dilution as described in 
Experimental Procedures. 
of age (Forrester et al., 1987; Nahm et al., 1983). In irradi- 
ated hosts reconstituted with a mixture of normal and xid 
stem cells, mutant B cells differentiate but are eventually 
completely displaced in the periphery, presumably by 
more efficient expansion of wild-type cells (Sprent and 
Bruce, 1984). In concert with these findings, rare mutant 
B cells in our B8 chimeras disappeared over time, while B 
cell numbers in the periphery of RAGP-I- chimeras, where 
competition could not occur, remained stable. 
An immature IgMllgD cell surface ratio and the selective 
inability to respond to TI-2 antigens are hallmarks of xid 
B cells (Wicker and &her, 1988). The B cells observed in 
the blood and spleens of our RAGP-‘-IBtk- chimeras exhibit 
these same cell surface and immune response character- 
istics. The abundance of peripheral B cell numbers in xid 
animals is approximately one-third that of normal animals 
(Sprent et al., 1985). In RAGP-I-IBtk- chimeras, we have 
not observed B cell abundance over 15% that of wild type. 
There are several possible explanations for the reduced 
numbers of B cells in these chimeras. Competition in the 
periphery cannot readily explain the difference in B cell 
abundance seen between our chimeras and xid animals, 
given the complete lack of RAGP-‘--derived lymphocytes 
in such hosts. The necessity for T cell help in the absence 
of full Btk function is indicated by the observation that 
xid x nu (athymic) mice, and thymectomized irradiated 
recipients of T cell-depleted xid bone marrow demon- 
strate a severe deficit of mature B cells (Wortis et al., 1982; 
Mond et al., 1982; Sprent and Bruce, 1984). Given this T 
cell dependence, the relative diminution in B cell numbers 
in the RAGP-‘- chimeras as compared with xid mice might 
be explained in part by subnormal T cell numbers. How- 
ever, this explanation is unlikely, given that the B:T ratios in 
RAG chimeras remain essentially constant over the 20%- 
100% of wild-type range of T cell abundance observed in 
the same animals. Most likely, much of the difference can 
be attributed to competition in the bone marrow between 
Btk- progenitors and early host RAGP-‘- progenitors (Kara- 
suyama et al., 1994; Melchers et al., 1994). In addition, 
background gene variation between the ES (129)lhost 
(mixed 129 x B6) strain combination and the original xid- 
bearing CBA/N strain may contribute to the difference. 
While the ability of xid 6 cell progenitors to mature in 
RAGP-‘- hosts has not been tested, our results from splenic 
and blood lymphoid studies in both B6 and RAG host chi- 
meras suggest that there exist no profound differences 
between Btk- and xid peripheral B cells. 
A Competitive Disability in the Expansion of Pre-B 
II Cells Distinguishes Btk from xid Lymphoid 
Progenitors 
In the bone marrow of normal animals, a large numeric 
expansion (1 O-fold or more) occurs between the pro- and 
pre-B II stages of B cell development (Melchers et al., 
1994) mainly as a consequence of the high percentage 
of large pre-B II cells that are actively cycling (Karasuyama 
et al., 1994; Osmond,. 1991). These cells initially express 
both cytoplasmic IgM heavy chains (c~H) and the VPRE-BI 
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)c5 surrogate light chain (SL) (Cherayil and Pillai, 1991) 
and both are necessary for expansion in the pre-B II stage 
(Karasuyama et al., 1994). Given the relative lack of Btk- 
ES-derived B cells in the periphery of our B6 chimeric 
animals, we sought to track the development of both B6- 
and Btk- ES-derived B cell progenitors in an attempt to 
define point(s) along the pathway at which Btk might nor- 
mally exert its effects. By scoring the relative numbers of 
B6- and ES-derived precursors passing from the pro-l 
pre-B I through mature B cell stages, we observed a 
greater than 1 O-fold deficit in the ability of mutant progeni- 
tors toexpand between the pro-/pre-B I and pre-B II stages. 
In principle, this failure could be attributed to either inade- 
quate clonal expansion or excessive cell death at or imme- 
diately prior to the pre-B II cell stage. Since in the RAG,? 
host chimeras (where B cell development is blocked prior 
to the pre-B II cell stage) 6 cell numbers are both signifi- 
cantly restored and stable over time, an intrinsically in- 
creased rate of Btk- progenitor cell death at the pre-B II 
stage almost certainly does not explain the poor develop- 
mental capacity of these progenitors in B6 hosts. This find- 
ing suggests, therefore, that the attrition of maturing Btk- 
B cells observed in B6 chimeric bone marrow results from 
a competitive process. 
xid animals have relatively normal numbers of pro-B, 
pre-B, and maturing B cells in their bone marrow (Kincade 
et al., 1962). Moreover, the proliferative rate of cytoplasmic 
u+ pre8 cells and the production of small lymphocytes 
proceeds normally (Reid and Osmond, 1985). In xi&+ ani- 
mals, selection against xidcells in bone marrow is evident 
for surface IgM+ B cells, but not for B220+/lgM- pre-B cells 
(Forrester et al., 1987). The lack of selection against xid 
pre-B cells clearly distinguishes the xid phenotype from 
that of a true murine Btk- mutation as defined here. 
In humans, there is no skewing of X inactivation among 
CD19+/CD34+ early pre-B cells in female XLA carriers 
(Conley et al., 1994). But the ability of XLA patients to 
produce pre-B II cells is variable, and a generalized prolif- 
erative defect at this stage has been described (Campana 
et al., 1990). Our findings demonstrate that the Btk- B-cell 
lineage in the mouse manifests a similar abnormality in 
precursor cell expansion. Viewing these results in aggre- 
gate, the phenotypic heterogeneity resulting from loss of 
Btk function appears to be largely quantitative: in both 
mouse and human there is a competitive, but not absolute, 
compromise in B progenitor cell expansion. 
The Consequences of Btk Dysfunction: 
Reconciling Mouse and Man 
At least two patients with XLA have been shown to bear 
a BTK mutation in precisely the same codon as that af- 
fected in the xid mouse (de Weers et al., 1994a; Ohta 
et al., 1994) though the mutation is different (R28H, as 
opposed to the murine R26C). This observation suggests 
that mice and humans may be at least partially discordant 
regarding the necessity of Btk. However, meaningful com- 
parison is difficult: a high degree of clinical heterogeneity 
exists among XLA patients, and as more of the mutations 
involved in individual cases have been catalogued (Korn- 
feld et al., 1994; Duriez et al., 1994; Bradley et al., 1994; 
Conley et al., 1994) it is becoming increasingly apparent 
that there may be little (if any) correlation between the 
type of mutation present and the severity of disease in 
any given patient. Bone marrow- or T cell-specific back- 
ground genes, as well as the age of a patient and prior 
infection history, are likely to influence the severity of the 
disease. Many XLA patients appear to have low but mea- 
surable numbers of circulating B cells, and these cells 
exhibit the same IgM bri@YlgDdu” phenotype characteristic 
of both xid (Conley, 1985) and murine Btk- B cells. Given 
the similarities in mice and humans between circulating 
Btk- B cells, and the common defect in expansion to or 
within the pre-B II cell stage of B lineage development, 
we feel that Btk deficiency disease in both species yields 
an identical abnormality in B lymphopoiesis, with variable 
severity in humans, owing to the existence of both genetic 
and environmental modifying factors. XLA patients are, 
to an appreciable extent, self-selecting, and hence there 
is a considerable biasof ascertainment. Toour knowledge, 
there is no catalogue of humans bearing St/r mutations 
who are not sick, though such potentially xid-like individu- 
als may exist. 
What does Btk actually do? The kinase has been shown 
to be activated in response to FcsRl cross-linking in mast 
cells (Kawakami et al., 1994), and IL-5 treatment (Appleby 
et al., 1995) or ligation of surface immunoglobulin (Aoki, 
1994; Saouaf et al., 1994; de Weers et al., 1994b) in B 
cells. In addition, in a pre-B cell line it is constitutively 
phosphorylated on tyrosine residues (Aoki, 1994). Given 
a potential role in signal transduction, we speculate that 
Btk may not only be involved in the signaling activity of 
relatively mature cells, but also in the transduction of sig- 
nals, perhaps mediated by the pre-B cell receptor, regulat- 
ing expansion to or within the pre-B II stage of B-cell devel- 
opment. The R28C mutation, associated with the xid 
phenotype, has been shown to perturb an interaction be- 
tween the kinase and several PKC isoforms (Yao et al., 
1994). Our results suggest this mutation may affect the 
various signaling functions of murine Btk differentially. 
However, the close similarity between phenotypes re- 
sulting from this mutation and the fully disabling mutation 
that we have engineered argues that PH domain function 
is indispensable for Btk-mediated signal transduction, and 
almost certainly for the normal function of other proteins 
containing such structures. 
Experimental Procedures 
Construction of BTKN.1 Targeting Vector and Homologous 
Recombination in ES Cells 
A disruption vector was created using a 9 kb EamHl subclone from 
a 20 kb btk unique region mouse genomic clone (Figure 1 A, top) (Raw- 
lings et al., 1993) isolated from a 129Sv I genomic Ii brary (provided by 
P. Soriano). A 3.5 kb EcoRI-Spel fragment (containing coding exons 3 
cassette (in inverse orientatfon), and the resulting sequence cloned 
into the herpes simplex virus thymidylate kinase (tk) gene in pKS. 
When linearized, the vector contains 1.5 kb of 5’ sequence homology 
and 4 kb of 3’ homology adjoining the r/r cassette (Figure lA, middle). 
The vector was electroporated into 1 x 10 D3J8 (gift of R. Jaenisch) 
or REKP (Brandon et al., 1995; gift of S. f&Knight) ES cells on three 
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occasions, with conditions and 641 B/gancyclovir selection performed 
as described (Appleby et al., 1992) with the exception that REK2 cells 
were maintained on primary mouse embryonic fibroblast monolayers 
rather than on the ST0 fibroblast line. Clones were screened for homol- 
ogous integrations via genomic Southern blotting of ES DNA with a 
5’btk cDNA probe (coding exons l-5), and candidates evaluated with 
additional probing strategies (Figure 1 B). All clones used for analysis 
in chimeric animals were from either different electroporations or sepa- 
rate platings within a given electroporation. 
Blastocyst Injections and Transfers 
ES cells (15-20) from individual clones were injected into 3.5-dayold 
embryos harvested from C57BU6 or f?AGP+- mice (mixed 129/Sv and 
896 background, breeders for which were provided by F. W. Alt) and 
transferred into sham-mated Swiss Webster recipients as described 
(Robertson, 1967). B6 chimeras were housed in both specific patho- 
gen-free (SPF) and conventional facilities. RAGP+- chimeras were 
housed only under SPF conditions. 
Flow Cytometry 
Lymphocyte suspensions were prepared from whole organs or periph- 
eral blood, with spleen, bone marrow, and peripheral blood samples 
depleted of red blood cells using ammonium chloride as described 
(Cooke et al., 1991). Monoclonal antibodies (MAbs) conjugated to fluo- 
rescein isothiocyanate, phycoerythrin, or biotin and specific for murine 
B220(Caltag Labs, San Francisco, California)CD43, CD4, CD6, CD3s, 
LyQ.l (PharMingen, San Diego, California) and IgD (The Binding Site, 
San Diego, California), plus tricolor-conjugated streptavidin (Caltag 
Labs) were used tostain 1 x 108cellsasdescribed (Grosset al., 1995) 
with events collected in list mode files on a FACScan flow cytometer 
(Becton Dickinson) with Lysis II software, and analyzed with Reproman 
Software version 2.07 (Truefacts Software, Seattle, Washington). 
B Cell Isolation and Sequence Analysis of btk Transcripts 
Splenocytes (2 x 10’) from a 129 control mouse and a RAGP-‘-IBtk- 
chimeric animal were stained with MAbs specific for CD3 (fluorescein 
isothiocyanate-conjugated) and 8220 (phycoerythrin-conjugated) as 
described above. B22O+/CD3- cells (1 x 105) with lymphoid forward/ 
side scatter characteristics were sorted on a dual laser FACStar Plus 
instrument (Becton Dickinson lmmunocytochemistry Systems, San 
Jose, California) and frozen. Total nucleic acids were prepared as 
described (Gross et al., 1995) and used for RT-PCR with protocols 
and materials from GIBCO BRL (Gaithersburg, Maryland) and Perkin- 
Elmer Cetus (Norwalk, Connecticut). Gel electrophoresis, hybridiza- 
tion, and probing were accomplished with standard procedures. btk 
primer sequences (defined based on the known btk genomic structure) 
(Sideras et al., 1994) were the following: exon 1,5’-ATGGCTGCAGTG 
ATACTGGAGAGC-3’; exon 2, 5’-AGAAGAGGCAGTAAGAAAGGT- 
TCA3’; exon 2*, 5%AATCTGTClTTCTGGTGGGGGAT-3’; exon 3, 
5’-AGGAGAGGTGAGGAGTCTAGTGAA-3’; exon 4, S-GTTGTATAT- 
GATGAAGGACCTCTC3’; exon 516, 5’~CCAGGlTTTAAGClTCCA- 
TTCCTG-3’; exon 6, 5’-GTAGGGGGAAGAGGCllTTTCGTT-3’; 
exon 12/l 3,5’-TTTTCCCATGATCCATAGCCCAGGC-3’; and exon 13, 
5’-AGCTCCITCAAGAAGGTGAGGTCC-3’. Mutant and wild-type prod- 
ucts amplified with the exon 1 and exon 516 primer pair were excised 
from ethidium bromide-stained agarose gels, digested with Pstl and 
Hindlll (which cut uniquely within primers 1 and 5/6, respectively), and 
ligated into pKS (Stratagene, La Jolla, California). Sequencing was 
performed according to the chain termination method (Sanger et al., 
1977) using Sequenase Version 2.0 (United States Biochemicals, 
Cleveland, Ohio). 
Serology 
Animals were pre-bled (200 ul) and immunized 2 months postweaning 
with 10 ug of DNP-Ficoll in phosphate-buffered saline (provided by 
S. Bondada) intraperitoneally on day 0. Mice were bled on day 8, 
immunized intraperitoneally with 100 trg of KLH (Sigma Chemical 
Company, Saint Louis, Missouri) in a 1:l homogenate with complete 
Freund’s adjuvant (Life Technologies, Incorporated, Grand Island, 
New York), and bled once more on day 18. 
Anti-DNP immunoglobulin isotype levels were determined with a 
modified sandwich enzyme-linked immunosorbent assay (ELISA) as 
described (Renshaw et al., 1994). In brief, individual wells of 96well 
plates (Flow Laboratories, Incorporated, McLean, Virginia) were 
coated with anti-mouse IgM antibody(Southern BiotechnologyAssoci- 
ation, Birmingham, Alabama) and blocked with 5% nonfat dry milk in 
phosphate-buffered saline. Plates were then incubated with serially 
diluted test serum samples. Biotinylated TNP-bovine y globulin (TNP- 
BGG; cross-reacts with anti-DNP antibodies) was used as a third step 
followed by horseradish peroxidase-conjugated streptavidin (Zymed, 
South San Francisco, California). All assays were developed using the 
TMB Microwell peroxidase substrate system (Kierkegaard and Perry 
Laboratories, Incorporated, Gaithersburg, Maryland). Plates were then 
read on a Dynatech ELISA reader (Dynatech Labs, Incorporated, 
Chantilly, Virginia). 
Anti-KLH IgM levels were determined by a direct ELISA method. 
In brief, wells were coated with 1 mg/ml KLH in phosphate-buffered 
saline and blocked with 5% nonfat dry milk. Serially diluted serum 
samples were added, followed by horseradish peroxidase-conjugated 
goat anti-mouse IgM (Southern Biotechnology Association). Plates 
were developed with peroxidase substrate and analyzed as described 
above. 
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